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Department of Biomedical and Pharmaceutical Sciences, College of Pharmacy, University of Rhode Island, Kingston, RI,
United States
Complex cell cultures are more representative of in vivo conditions than conventionally
used monolayer cultures, and are hence being investigated for predictive screening of
therapeutic agents. Poly lactide co-glycolide (PLGA) polymer is frequently used in the
development of porous substrates for complex cell culture. Substrates or scaffolds with
highly interconnected, micrometric pores have been shown to positively impact tissue
model formation by enhancing cell attachment and infiltration. We report a novel alginate
microsphere (AMS)-based controlled pore formation method for the development of
porous, biodegradable PLGA microspheres (PPMS), for tissue engineered lung tumor
model development. The AMS porogen, non-porous PLGA microspheres (PLGAMS)
and PPMS had spherical morphology (mean diameters: 10.3 ± 4, 79 ± 21.8, and
103 ± 30 µm, respectively). The PPMS had relatively uniform pores and a porosity
of 45.5%. Degradation studies show that PPMS effectively maintained their structural
integrity with time whereas PLGAMS showed shrunken morphology. The optimized
cell seeding density on PPMS was 25 × 103 cells/mg of particles/well. Collagen
coating on PPMS significantly enhanced the attachment and proliferation of co-cultures
of A549 lung adenocarcinoma and MRC-5 lung fibroblast cells. Preliminary proof-of-
concept drug screening studies using mono- and combination anti-cancer therapies
demonstrated that the tissue-engineered lung tumor model had a significantly higher
resistance to the tested drugs than the monolayer co-cultures. These studies indicate
that the PPMS with controllable pore diameters may be a suitable platform for the
development of complex tumor cultures for early in vitro drug screening applications.
Keywords: controlled pore formation, scaffold, tissue engineered, drug screening, microparticles, lung cancer
co-culture
INTRODUCTION
According to American Cancer Society estimates, lung cancer is the most commonly diagnosed
human cancer, with 228,150 new cases (116,440 in men and 111,710 in women) and 142,670
deaths (76,650 in men and 66,020 in women) expected from this condition in 2019 (Siegel
et al., 2019). Despite the advances in sophisticated early diagnostic techniques and treatments,
the overall prognosis of lung cancer patients remains poor with a 5-year survival rate
of only 15% (Edelman et al., 2001). Further, the development of an anti-cancer drug by
pharmaceutical companies is exceedingly expensive with an estimated $648 million spent
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in this process; yet 95% of anti-cancer drugs in clinical trials
tend to fail due to toxicity and inefficacy despite demonstrating
acceptable anti-cancer activities during preclinical experiments
(Moreno and Pearson, 2013; Prasad and Mailankody, 2017).
The differences in the outcomes can be partly attributed to
the fact that currently available in vitro cancer models fail
to recapitulate clinical cancer conditions, and hence often
provide inaccurate results during drug development. Two-
dimensional (2D) culture of cells as a monolayer on glass
or tissue culture plastic (TCP) are most commonly used for
in vitro investigation of drugs, but these fail to mimic the
three-dimensional (3D) nature of in vivo environments. While
in vivo models can give more reliable results, it is not feasible
for large-scale drug screening purposes at preliminary stages of
drug development. A major barrier to cancer drug discovery
today, therefore, is the lack of predictive experimental in vitro
human tumor models for early screening of promising drug
candidates.
There has been a paradigm shift especially in the last decade
toward the development of 3D in vitro tumor models that
can recapitulate the tumor microenvironment for reliable
chemotherapeutic drug testing and optimization. Three-
dimensional models proposed include spheroids developed
using spinner flasks (McMillan et al., 2016; Yakavets et al.,
2017), non-adherent dishes or hanging drop method (Costa
et al., 2018), scaffolds (McMaster et al., 2019), gels made of
extracellular matrix components like collagen (Liu C. et al.,
2018), and microparticles mostly of non-uniform porosities
and pore-sizes (Sahoo et al., 2005). However, several models
being studied today have faced issues in terms of maintaining
reproducibility between batches, allowing uniform diffusion of
oxygen and nutrients to enable cell growth, and controlling the
sizes of the tissue models formed (Choi et al., 2010). For example
hanging drop method is limited by tedious steps and the difficulty
in changing media, spinner flask method involves long-term
incubation for the development of spheroids, and non adherent
3D culture approaches often require an extra step of coating the
surface with non-adherent material, which can lead to higher
costs or uneven coating (Wang and Yang, 2008; Patel et al., 2015).
Microspheres offer greater advantage over other methods as it
provides a large surface area for cell attachment and proliferation
(Hacker et al., 2003). Porous microspheres facilitate attachment,
proliferation, infiltration, and extracellular matrix production
by the cells (Horning et al., 2008). Besides, porous microspheres
offers better control over the spatial and physical parameters of
the in vitro tumor models formed, compared to other approaches
(Horning et al., 2008). This will reduce batch-to-batch variations
and help obtain consistent and repeatable results during in vitro
pharmaceutical drug testing. Both large polymeric porous
(PPMS) and non-porous (PLGAMS) microspheres prepared
using biocompatible, biodegradable polymers like PLGA (poly
lactic-co-glycolic acid) have been used previously as substrates
for development of tumor and tissue models in vitro (Sahoo
et al., 2005; Horning et al., 2008; Kang et al., 2008; Kang and
Bae, 2009). We have previously reported the development
of PPMS using different kinds of porogens for lung tumor
model development (Kuriakose et al., 2019). The pores on
these particles, were non-uniform and too small to allow cell
infiltration.
Based on the above background, we hypothesized that
large PLGA microparticles made porous using our innovative
controlled pore formation method would facilitate the generation
of a more representative lung tumor model than other
techniques. Our rationale was that the interconnected pores
of controlled diameters on the PLGA microparticles will
facilitate uniform nutrient, oxygen, and waste diffusion, which
in turn will strongly influence uniform cell distribution
throughout the scaffold, and cell infiltration and growth through
the pores. Our novel alginate microsphere (AMS) porogen-
based controlled pore formation method is an improvement
over existing approaches for making scaffolds with large,
relatively uniform, interconnected pores for tissue engineering
applications. A schematic representation of the preparation of
porous PLGA microspheres using AMS as porogen, and its
use in the development of lung tumor model is shown in
Figure 1. Developed PPMS were characterized by advanced
analytical techniques. We report for the first time the generation
of lung cancer co-cultures using A549 lung adenocarcinoma cells
and MRC-5 human lung fibroblasts, on PPMS. A comparative
correlation between PPMS and PLGAMS was also generated.
Further, series of anticancer drugs were tested alone and in
combination using the fabricated in vitro lung cancer model
and compared with 2D co-culture system. To determine the
drug efficacy in 2D monolayer and developed lung cancer
tumor model, we tested six anti-cancer drugs Cisplatin (Cis),
Doxorubicin (Dox), Curcumin (Cur), Paclitaxel (Ptx), Etoposide
(Eto), Gemcitabine (Gem) and the combinations of Cis with Eto
or Gem, which are currently used in clinical practice for the
treatment of lung cancer. Cell viability and confocal imaging was
performed after drug treatment to assess the responses of the 2D
and the PPMS-based models to the same concentration of drugs.
MATERIALS AND METHODS
Formulation and Characterization of
AMS Porogen
The AMS porogen was formulated by water-in-oil emulsion
technique as described by Zhu et al. (2005) with minor
modifications. Briefly, 5 ml of aqueous phase [3.1% w/v sodium
alginate solution in de-ionized (DI) water] was emulsified in
14 ml of oil phase (1.97% v/v Span 85 solution in soybean
oil) by vortexing for 10 min. Then, 1 ml of 16.4% v/v tween
80 solution in soybean oil was added and vortexed again for
10 min. AMS formed in the emulsion were crosslinked by
dropwise addition of 3.5 ml of CaCl2 solution (10% w/v) while
stirring at 500 rpm, 20 min. AMS were hardened by dropwise
addition of isopropyl alcohol (IPA) and then centrifuged at
200g for 10 min at RT (23◦C). The particles were then washed
with IPA: water (50:50% v/v) once and then with distilled
water (DW) to ensure complete removal of oil and surfactants.
Generated pellet was resuspended in DW and stored at 4◦C for
further characterization. Morphology and diameter of the AMS
was analyzed by brightfield microscope (EVOS R© FL Auto Cell
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FIGURE 1 | Schematic representation of preparation of Porous PLGA microspheres using AMS as porogen and its use in the development of lung tumor model.
Imaging System, Life Technologies corporation, Bothell, WA,
United States).
Formulation of PPMS and PLGAMS
Non-porous PLGA microspheres were prepared by a standard
single emulsion (oil-in-water) solvent evaporation technique
(Chaisri et al., 2009) whereas PPMS was developed by double
emulsion solvent evaporation technique using AMS as the
porogen. For PLGAMS, the organic phase [10% w/v of
PLGA (Sigma Aldrich, United States, Resomer RG 503H, acid
terminated; lactide:glycolide ratio 50:50, Mol wt 24,000 to 38,000)
in 1 ml of chloroform] was added dropwise to 20 ml solution
of 0.5% w/v polyvinyl alcohol (PVA). The formulation was
stirred overnight for solvent evaporation, and then centrifuged
at 4000 rpm at 10◦C for 10 min to yield purified PLGAMS.
For PPMS, the primary emulsion was prepared by vortexing
AMS (3, 6, or 9 mg) with 2 ml of organic phase (2.5% w/v of
PLGA in chloroform). This primary emulsion was then added
dropwise in 10 ml 0.5% w/v PVA solution and stirred overnight
for solvent evaporation. The formulation was then centrifuged at
4000 rpm at 10◦C for 15 min prior to treatment with 1 ml of
EDTA solution (14.62 mg/ml) to digest AMS. The mixture was
then again washed with DW to yield purified PPMS. Both the
particles were then finally freeze dried and stored at −20◦C for
further characterization.
Characterization of PLGAMS and PPMS
Formulated PLGAMS, and PPMS were evaluated for particle size
and morphology using EVOS R© FL Auto Cell Imaging System and
Scanning electron microscope (SEM, Zeiss Sigma, United States).
Images of all formulations were analyzed for particles size
distribution by ImageJ software. Porosity of PPMS was analyzed
with liquid displacement method following literature’s method
(Nazarov et al., 2004; Zu et al., 2012). Energy-dispersive X-ray
spectroscopy (EDS) was performed to confirm porogen leaching.
Both PLGAMS and PPMS were also evaluated using cryo-SEM
to confirm the internal structure of particles. For cryo-SEM, a
small drop of the sample (approximately 5 µl) was placed on the
holder and frozen in liquid nitrogen slush. Frozen specimen was
immediately placed in the vacuum chamber of SEM and cooled to
−130◦C where the particles were fractured using a cold flat-edge
knife and imaged using FE-SEM system.
Degradation Studies on PLGAMS and
PPMS
Particles were sterilized by treatment with 70% ethanol, before
use in the experiment. To study the degradation kinetics, 3 mg of
either PPMS or PLGAMS in pre-weighed tubes was incubated in
2 ml of Dulbecco’s Modified Eagle Medium (DMEM) completed
using 10% fetal bovine serum and 1% penicillin-streptomycin,
at 37◦C. At predetermined timepoints (day 1, 2, 4, 7, 14, 21,
and 28), the particles were washed, centrifuged (2000 rpm,
10 min at 10◦C) and lyophilized. Particle weights were measured
at different time points and the surface morphology was
determined by SEM.
In vitro Cell Culture Experimentation
MRC-5 lung fibroblast (Catalog CCL-171) and A549 lung
epithelial cells (Catalog CCL-185) were purchased from
American Type Culture Collection (ATCC, Manassas, VA,
United States), and cultured in complete DMEM. MRC-5 at
passages 3–6 were used throughout our studies. For all in vitro
experiments, agarose-coated 96 well plates were used. These
were prepared by adding 50µl of 1% agarose to the wells
followed by sterilization under UV light. The particles used in
the experiments were sterilized by 70% ethanol.
Degradation Behavior of PLGAMS and
PPMS in Presence of A549 Lung Cancer
Cells
To visualize particle degradation in the presence of cells, cells
at seeding density of 5 × 104 cells/well were added to agarose-
coated wells containing sterilized PPMS or PLGAMS. The plates
were kept in a CO2 incubator at 37◦C and the media was replaced
every 3 days. At predetermined time points (1, 2, 4, 7, 14, 21, and
28 days), half of the particles were trypsinized whereas the other
half was fixed by using 2.5% glutaraldehyde for 20 min, followed
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by treatment with 50, 60, 70, 80, 90, and 100% v/v ethanol for
10 min each. The two halves were dried in hood for solvent
evaporation and visualized by SEM.
Optimization of Cell Seeding Density
For this study, A549 cells at different seeding densities (5 × 103,
10 × 103, 25 × 103, and 50 × 103 cells/well/mg of particles)
were incubated with sterilized PPMS or PLGAMS on agarose-
coated well plates. The media was replaced every 3 days. At
predetermined time points (1, 3, 5, 7, 14, and 21 days), the media
was carefully removed from each well using a 26G syringe and
WST-1 assays were performed as per manufacturer’s instructions.
A cell standard curve was plotted from absorbance values in
WST-1 assays of known number of cells (5 × 103, 10 × 103,
25 × 103, 50 × 103, and 100 × 103 cells/well). Based on the
calibration curve obtained, the number of viable cells on the
PPMS and PLGAMS at each timepoint was determined. Further
Live/DeadTM assay (Invitrogen, Carlsbad, CA, United States)
was done as per the standard protocol on days 7 and 14 to
confirm cell viability. Stained cells on particles were observed
under Confocal laser scanning microscope (CLSM, Nikon Eclipse
Ti2) with bright field, FITC (green), Cy5 (red) channels.
Coating of Collagen on PPMS
Collagen is known to improve the cell attachment and allow
better proliferation on the substrate (Kleinman et al., 1981). The
PPMS were coated with collagen type I (C7661, Sigma-Aldrich,
United States) as per the method by Hong et al. (2005) with
slight modifications. Briefly, PPMS were immersed in 6% v/v of
hexanediamine in n-propanol solution with stirring for 8–10 min
at room temperature. After 10 min, the particles were washed
thoroughly using DW. The surface modified PPMS were then
immersed in 1% glutaraldehyde solution at room temperature for
4 h and then thoroughly washed using DW to ensure complete
removal of excess glutaraldehyde. The PPMS were then immersed
in a solution of 0.5% collagen in 3% acetic acid at 4◦C for
24 h with occasional shaking. Collagen coated PPMS (Col-PPMS)
were washed with DW to remove the excess of collagen, and then
lyophilized for further characterization.
Characterization of Collagen-Coated
PPMS
Mouse Collagen I Monoclonal Antibody (catalog CSI 008-01-
02) and goat anti-mouse IgG-FITC (catalog sc-2010) antibodies
were purchased from Invitrogen and Santa Cruz Biotechnology,
respectively, and were used without further purification.
Lyophilized PPMS and Col-PPMS were first dissolved in PBS
and blocked with 5% bovine serum albumin (BSA) for 1 h at
4◦C. Then the particles were washed with Tris buffer saline with
0.1% v/v tween-20 (TBST) before incubation with Collagen I
monoclonal antibody (dilution 1:1000) overnight at 4◦C. Next,
the particles were washed with TBST 3–4 times and incubated
with secondary antibody (dilution 1:2500) for 4 h followed
by washing with TBST. At each step, particles were collected
via centrifugation at 100 g in for 5 min. Finally, Col-PPMS
and PPMS were observed under Nikon CLSM with bright field
and FITC channels.
Co-culture of A549 and MRC-5 on PPMS
Studies were done to ensure that both A549 and MRC5 cells
can attach and grow on the particles, and that both cells are
viable. One milligram of either Col-PPMS or PPMS suspension in
DMEM were added to the agarose pre-coated 96-well plates prior
to cells seeding. Then, MRC-5 and A549 cells were separately
pre-stained with Vybrant DiO and DiD cell-labeling solutions
(Invitrogen), respectively followed manufacture’s protocol, before
addition onto the particles. The pre-stained cells were mixed in
DMEM at 1:1 cell ratios and then seeded at 25× 103 cells/mg/well
on either Col-PPMS or PPMS suspension. At each time point,
particle with cells were collected, washed with Dulbecco’s
phosphate buffered saline (DPBS) and imaged using Nikon
Inverted Confocal Microscope with FITC and Cy5 channels for
MRC-5 and A549 cells, respectively. In parallel, non-stained
MRC-5 and A549 were seeded at 25 × 103 cells/mg of PPMS or
Col-PPMS/well (1:1 ratio of cells). At each time point (day 1, 3, 5,
and 7), the media was removed, the particles were washed with
DPBS, and WST-1 assays were performed. Separately, cells on
the particles were stained with Live/DeadTM, and then observed
via Nikon CLSM with FITC and Cy5 channels for live and dead
cells, respectively.
Screening of Anti-cancer Drugs Using
Tissue Engineered Lung Tumor Model
and 2D Models
The anti-cancer effect of drugs was studied by using
the developed co-culture lung tumor model and its
corresponding 2D cell culture. The optimized seeding density
of 25 × 103 cells/mg/well was used to seed the cells at 1:1
ratio on Col-PPMS in the agarose coated 96 well plate. Cells
were incubated for 5 days to develop the lung tumor model
on PPMS. The average number of cells growing on PPMS at
day 5 was determined to be 22 × 103 cells/well based on our
cell seeding optimization studies. Therefore cells were seeded
at 22 × 103 cells/well for the monolayer culture, 1 day before
the start of anti-cancer screening. The protocol for cell seeding
was optimized to obtain approximately same cell count in both
experimental groups. The PPMS-based lung tumor model and
the 2D cell cultures were starved for 6 h in serum free media
and then exposed to anti-cancer drugs at IC50 values such as
Cis (24.27 µM) (Zhuo et al., 2015), Dox (1.4 µg/ml) (Hu et al.,
2008), Cur (36.69 µg/ml) (Zhu et al., 2017), Ptx (2.36 µg/ml)
(Yuan et al., 2008), Eto (44 µM) (Rho et al., 2009), and Gem
(47.7 µM) (Rho et al., 2009). To evaluate the effect of Cis in
combination with Eto and Gem, two strategies were used. In
the first strategy, the cells was exposed to separately to either
of the two drug combinations for 24 and 72 h (simultaneous
addition). In the second strategy, the cell cultures were exposed
to Cis for 24 h and then with Eto or gemcitabine for another
48 h (subsequent addition). All the samples were evaluated after
24 and 72 h using WST-1 assay and Live/Dead assay as per the
standard protocol.
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RESULTS
Formulation and Characterization of
Porogen
Alginate microsphere were successfully formulated by emulsion
method and characterized by brightfield microscope to evaluate
the particle diameter and morphology. They had a mean diameter
of 10.3 ± 4 µm, and spherical morphology (Figure 2A).
A 1:2 v/v ratio for tween 80: span 85 and 10% w/v aqueous
solution of calcium chloride were found to be optimal for
obtaining AMS with uniform particle sizes. EDS analysis of AMS
shows the presence of Ca ion peak confirming the crosslinking
(Supplementary Figure S1).
Formulation and Characterization of
PLGAMS and PPMS
The PLGAMS had a smooth surface with clear spherical
morphology and a mean diameter of 79 ± 21.8 µm (Figure 2B).
PPMS also showed predominantly spherical morphology with
diameter of 103 ± 30 µm. Controlled pore formation on the
PPMS was achieved by digesting the incorporated AMS. The
surface of PPMS pre-AMS digestion was rough (Figure 2C),
while it became porous (Figure 2D) post digestion of AMS using
EDTA. Using ImageJ with particle analysis tool (Supplementary
Figure S2), the pore diameter was determined as 7.4 ± 4.4 µm.
Using liquid displacement method (Nazarov et al., 2004; Zu et al.,
2012), porosity of PPMS was determined as 45.5%. SEM images of
different formulations (Figures 2E–G) clearly shows that the 6:50
w/w ratio of AMS: PLGA generated PPMS with well-distributed,
interconnected pores, and this formulation was chosen for
further investigation. Internal structure of PLGAMS and PPMS
analyzed by cryo-SEM (Figures 3A,B) clearly demonstrated the
uniform, interconnected pore network within the PPMS whereas
PLGAMS showed solid and impermeable structure. EDS spectra
of PPMS without EDTA treatment showed the presence of
prominent Ca++ ions peaks whereas the EDTA treated PPMS did
not show the presence of Ca++ peak which confirms the efficient
digestion of AMS (Figures 3C,D).
Degradation Studies on PLGAMS and
PPMS
The effect of complete media on PLGAMS and PPMS in terms
of morphology and changes in sample weight were investigated.
SEM images (Figure 4A) taken at different timepoints clearly
show that the PPMS effectively maintained its structural integrity
with time whereas PLGAMS showed shrunken morphology. Both
PLGMS and PPMS underwent significant changes in weight
within 3 weeks (Figure 4B). However, the differences in weight
between both particles were not statistically significant. A greater
loss in weight of PPMS (75.8 ± 14.5% of original weight) was
observed on day 28 when compared to PLGAMS (60.3 ± 14%
of original weight).
Degradation Behavior of PLGAMS and
PPMS in Presence of Cells
The effect of A549 cell growth on the particles was studied.
Images from SEM clearly demonstrate that both PPMS and
PLGAMS supported cell growth. After trypsinization, the cells
were successfully detached from the particle surface and the
pores were clearly visible in PPMS, whereas in PLGAMS the
surface morphology was distorted with time (Supplementary
Figure S3). Images also reveals that the pore structure in PPMS
was intact for 28 days.
Optimization of Cell Seeding Density
WST-1 assay was performed to determine the optimal seeding
density for cell culture on PPMS and PLGAMS (Supplementary
Figure S4). Cells growing on PPMS gave comparatively higher
absorbance values than those growing on PLGAMS. There was
a significant difference between cell attachment on PPMS and
PLGAMS at 5000 (Figure 5A), 10,000 (Figure 5B), and 25,000
(Figure 5C) cells per well density, whereas 50,000 cells/well
(Figure 5D) did not show a linear growth of cells. Based
on the growth curves, 25,000 cells/well was considered to
be optimal. Approximately 18,800 cells/mg of PPMS was
observed on day 5 using this seeding density, compared to
17,625 cells/mg of PLGAMS on the same day. All the seeding
densites except for 50,000 cell/well demonstrated the log phase
till day 7 followed by a lag phase after day 7 time point.
Live/Dead analysis of PPMS and PLGAMS on day 7 and 14
are shown in Figure 5E. PPMS shows more of live cells with
very less dead cells when compared to PLGAMS on day 7
and 14.
Collagen Coating on PPMS
The qualitative and quantitative outcome of the collagen
coating on PPMS was confirmed by immunochemistry. It
can be observed from Figures 6A,B that col-PPMS strongly
expressed green fluorescence whereas non-coated PPMS
yielded none. The fluorescence was produced by the FITC
conjugated secondary antibodies where they bound to the anti-
collagen primary antibodies. Our images confirm qualitatively
that the anti-collagen antibodies could successfully bind to
the collagen coating on Col-PPMS. Analyzing fluorescent
intensity with ImageJ also showed a significant difference
(Figure 6C) between the two groups (p = 0.003 in t-test
for two groups with two-tail distribution and unequal
variance), confirming that the collagen coating on PPMS
was successful.
Viability of A549-MRC-5 Co-cultures on
the Microsphere Substrates
It can be observed from Figures 7A,B that from days 1 through
7, there were more cells bound to collagen-coated PPMS than
those on non-coated PPMS. Confocal images from day 5 (low
magnification) and day 7 (high magnification), shows an overlap
of red and green fluorescence (light green to light yellow) which
indicates that the MRC-5 (DiO dye, green) and A549 (DiD
dye, red) can be co-cultured successfully on the same particles
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FIGURE 2 | Characterization and optimization of PPMS. Brightfield image of (A) AMS porogens showing uniform spherical morphology. SEM images of (B) PLGAMS
showing smooth, spherical morphology, (C) PPMS before porogen leaching with rough surfaces, and (D) PPMS after porogen leaching with relatively uniform pores
on the structure upon removal of AMS; SEM images of optimization of PPMS based on ratio of AMS (mg) to PLGA (mg) (AMS:PLGA) used in the formulation – (E)
3:50, (F) 6:50, and (G) 9:50; Scale bars: (A,B), 100 µm; (C), 20 µm; (D), 50 µm; (E–G), 20 µm.
of collagen-coated PPMS. To study cell growth on PPMS and
PLGAMS, WST-1 cell viability assays were used and absorbance
readings from the cells grown on particles were compared to
those from a cell standard. It can be observed from Figure 7C
that there were more cells binding on collagen-coated PPMS.
Significance difference was obtained for all single day except day
7 with p < 0.05 or p < 0.01 on t- tests. In accordance with WST-
1 studies, Live/Dead assays also showed more alive cells (green
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FIGURE 3 | Characterization of pores on PPMS. Cryo-SEM images of (A) PLGAMS (scale bar: 10 µm) showing smooth surface; (B) PPMS (scale bar: 20 µm) with
uniform interconnected porous structure. EDS analysis of (C) PPMS before leaching by EDTA showing calcium peaks due to presence of calcium crosslinked AMS
within the particles; and (D) disappearance of calcium peak in the PPMS after leaching of AMS porogens by EDTA treatment.
fluorescence) and less dead cells (red fluorescence) on Col-PPMS
compared to non-coated PPMS (Supplementary Figure S5).
Screening of Anti-cancer Drugs Using
the Tissue Engineered Lung Tumor and
2D Models
Efficiency of anti-cancer drugs such as Cis, Dox, Cur, Ptx, Eto,
Gem, and the combinations of Cis with Eto or Gem were
evaluated using the developed in vitro lung tumor model and
the 2D monolayer co-culture after 24 (Supplementary Figure S6)
and 72 h (Figure 8). After 24 h of treatment with the anti-cancer
drugs, a significant difference was noticed between the Col-
PPMS cultures and 2D monolayer co-cultures in their responses
to Cur, Cis + Eto (CE), and Cis + Gem (CG) combinations.
However, after 72 h of treatment, a significant difference in
the responses of the Col-PPMS cultures to all the drugs was
observed, when compared to the 2D monolayers. In combination
treatment, it was observed that successive addition of drugs
(C−E and C−G) respectively resulted in greater cell death when
compared to simultaneous addition (CE and CG). All drugs
followed the same trends for both models – greater viability
was observed for cells growing on Col-PPMS compared to
those growing as a monolayer, when subjected to the same
concentration of drugs. Specifically, successive addition of Cis
and Gem demonstrated most anti-cancer activity while Eto was
the least toxic toward cells cultured on Col-PPMS. Cis and Gem
combination also demonstrated better efficacy compared to the
combination of Cis and Eto when tested against the A549-MRC-
5 co-cultures on Col-PPMS. The Cis – Eto combination did
not show significant difference in 2D monolayer co-culture in
both the successive and subsequent treatment strategies, whereas
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FIGURE 4 | Degradation studies. (A) SEM images of PPMS and PLGAMS in complete media at 37◦C PPMS shows degradation with clear pores until 28 days
whereas PLGAMS degradation results in distorted morphology of the particles due to autocatalytic effect; (B) decrease in weights of PPMS and PLGAMS in cell
media at 37◦C observed over time.
a significant difference was observed in the response of the
Col-PPMS co-cultures to both treatments. The Col-PPMS model
also demonstrated significant resistance to the combination of
Cis – Gem than the 2D monolayer cultures for both treatment
strategies. Live/Dead images of co-cultured cells at 6 and 24 h
(Supplementary Figures S7–S10) post treatment showed clear
anti-cancer effects of the drugs for both monolayer and Col-
PPMS cultures (Supplementary Figures S7, S10). Treatment of
the models with drugs for 72 h (Figure 9) resulted in greater cell
death in both models, which concurs with the data obtained.
DISCUSSION
Monolayer cell culture models are extensively used to screen
and investigate the efficacy of anti-cancer drugs. However, they
are unable to mimic cell-cell interactions, paracrine signaling
and cell-matrix interactions seen in an in vivo environment
(Kapałczyńska et al., 2018). Although epithelial cell properties are
mimicked reasonably well in both 2D and 3D (Duval et al., 2017),
the differences for cancer cells (and stem cells) are significant,
especially in term of gene expression (Loessner et al., 2010),
cell proliferation for tumor development (Duval et al., 2017),
migration for cancer metastasis (Tibbitt and Anseth, 2009; Duval
et al., 2017) and stiffness for drug resistant (Duval et al., 2017).
The 3D cell cultures are necessary to represent drug, oxygen
and nutrient diffusions, as well as cell necrotic/proliferative states
that reflect more accurately the characteristics of the in vivo
environment (Kapałczyńska et al., 2016; Duval et al., 2017).
Further, cells in 2D culture are confined to a single plane and
thus encounter minimal or no resistance from the surrounding
ECM. In this manner, they demonstrate higher migration rate
compared to cells grown in tissue engineered scaffold models
(Tibbitt and Anseth, 2009). Therefore there is a significant
difference in the expression of specific biomarkers, generation of
extracellular matrix, metabolic function, and cellular receptors
from the scaffold-based tissue culture models to 2D (Horning
et al., 2008).
While several techniques for culturing cells in a 3D format
have been developed in the past decade, most techniques are
limited by batch-to-batch variability, cumbersome techniques,
high cost, and low throughput methods (McMillan et al., 2016;
Yakavets et al., 2017; Costa et al., 2018). In this work, we
propose the use of AMS as a novel porogen which allows us
to control pore formation on polymeric substrates, which can
then be used to develop tissue engineered lung tumor models.
AMS formulated by water-in-oil emulsion technique showed
particle diameter in the range of 10.3 ± 4 µm. Zhu et al. (2005)
had used a similar method for the synthesis of AMS for drug
delivery application, and their particles had an average diameter
of 4.5 µm and were uniformly dispersed as observed by us in this
research. Unlike AMS, other porogens reported in the literature
such as water, salt, ammonium bicarbonate and gelatin fail to
produce uniform and large pores (Fan et al., 2013). The AMS-
incorporated particles developed by us were treated with EDTA.
The subsequent chelation with calcium ions led to reversing of
the gel structure of AMS to fluidic state leading to the generation
of relatively uniform pores (Chueh et al., 2010). Further, alginate,
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FIGURE 5 | Cell seeding optimization experiments. PPMS facilitated greater A549 cell attachment and growth compared to PLGAMS. Seeding densities used
include (A) 5 × 103, (B) 10 × 103, (C) 25 × 103, (D) 50 × 103 cells/mg of microparticles/well. Data as mean ± SD, n = 3; (E) Live/Dead staining shows greater cell
death (red) on PLGAMS than on PPMS, which had more viable cells (green) (optimized cell seeding density – 25 × 103 cells/mg/well; scale bars = 100 µm).
Significant difference was analyzed by Student’s t-test (*p < 0.001, #p < 0.01, @p < 0.05).
which remains stable in acidic media tends to degrade in alkaline
medium by swelling followed by disintegration (Dhamecha et al.,
2019). The calcium ions released by the ion exchange with
sodium ions (alkaline) in the medium, and electrostatic repulsion
between the carboxylate anions further accelerates the swelling
and erosion of alginate gels (Lee et al., 2003) consequently leading
to the generation of pores. EDS analysis confirmed that the peak
of Ca++ disappeared upon treatment of PPMS with EDTA. The
pore diameters on the PPMS were similar to the diameter of
the entrapped AMS. Cryo-SEM images of particle cross-sections
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FIGURE 6 | Confirmation of collagen coating on PPMS by immunostaining. Green fluorescent particles indicated successful collagen coating on (A) Col-PPMS in
comparison to (B) non-coated PPMS. Scale bar: 100 µm. (C) Fluorescence intensity quantified by ImageJ showing significantly higher fluorescence from Col-PPMS
than from non-coated PPMS. Significant difference was analyzed by Student’s t-test.
clearly demonstrated uniform and interconnected pore networks
within the PPMS for cell and nutrient infiltration (Horning et al.,
2008; Fan et al., 2013), whereas PLGAMS showed a solid and non-
porous structure. Scaffolds with interconnected pores made using
synthetic biodegradable polymers, have been extensively used
in tissue engineering for cell growth and differentiation (Zhang
et al., 2015; Kuriakose et al., 2019).
The key factor in selection of polymer for the development
of porous scaffold is its biocompatibility, biodegradability,
degradation behavior and mechanical strength of developed
scaffold system. Once exposed to media and cells, a porous
scaffold should maintain mechanical properties and structural
integrity until the loaded cells adapt to the environment and
excrete enough extracellular matrix, etc. The degradation rate
of porous scaffolds affects cell vitality and growth overtime.
Based on the above the requirements, we selected PLGA (Mol wt
24,000–38,000) which have all the desired properties. PLGA is a
well-known USFDA approved biocompatible and biodegradable
polymer used for drug delivery. The polymer is robust and
shown to be used in tissue engineering. It degrades through
chemical hydrolysis of the unstable ester bonds to form lactic
acid and glycolic acid as non toxic byproducts. Further for tissue
engineering applications, there is a need of desirable mechanical
strength which was provided by PPMS (Wu and Ding, 2004).
For the development of PPMS based lung tumor model, there
is a requirement of sufficient mechanical strength so that the
scaffold can withstand the experimental condition for certain
number of days until the tissue model is developed. PPMS have
successfully used as a scaffold for various tissue engineering
applications. A correlation of degradation in media and with
cells overtime with changes in the morphology is explained in
following sections.
In addition to pore interconnectivity, scaffolds must also have
optimal degradation profiles to ensure that a stable substrate is
available for the lung tumor model development (Gu et al., 2016).
Both PPMS and PLGAMS underwent degradation in a linear
fashion with time, with no significant difference. Nevertheless,
SEM images clearly shows that the PPMS effectively maintained
its structural integrity until day 28 while PLGAMS started to
collapse after 2 weeks. The maintenance of structural integrity of
PPMS is suitable for long-term culture of lung tumors. In vivo
lung tumor models (injection of cancerous cell lines to nude
mice) are generally ready after 1–2 week(s) (Onn et al., 2003)
and last for 4–6 weeks (Onn et al., 2003; Isobe et al., 2013)
when tumors reach a threshold size such as 4 mm diameter
(Isobe et al., 2013). The reason for this distorted shape of
PLGAMS can be explained by the autocatalysis process, where
in the presence of media, ester linkages of PLGA particles
undergo hydrolysis initiating the degradation process. In the
non-porous particles, the acidic degradation products remains
encapsulated within and accelerates the reaction. The eventual
release of these highly concentrated degradation products upon
complete polymer degradation will affect cell viability. On
the other hand, the pores in PPMS provide channels for the
catalytic degradation products to seep out thus resulting in
comparatively intact morphology (Lu et al., 2000; Siepmann
et al., 2005; Wu and Ding, 2005; Yang et al., 2008; Pan and
Ding, 2012; Kuriakose et al., 2019). The greater decrease in
weight of PPMS with time in Figure 4B could be explained
by the removal of degradation byproducts during the washing
step at each timepoint. On the other hand, the majority
of the degradation byproducts of PLGAMS remained within
the particles for the duration of the study, and were not
cleared away during washing. The PPMS also maintained
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FIGURE 7 | Co-culture of MRC-5 and A549 (1:1 seeding ratio) at (A) low magnification (scale bar: 100 µm) and (B) high magnification (scale bar: 20 µm). Left,
phase contrast images; right, overlay of green (FITC channel) and red (Cy5 channel) fluorescent images. (C) Quantification of number of cells attached onto
Col-PPMS and PPMS showing significantly higher cell attachment on Col-PPMS at almost all timepoints. *p < 0.05 and #p < 0.01 with respect to cells growing on
PPMS of the same day of study.
its structure following cell growth while PLGAMS became
distorted following cell attachment, as observed during the
degradation study.
Following particle characterization, studies done to optimize
the cell seeding density for lung tumor model formation showed
that a density of 25 × 103 cells/mg/well was optimal. Greater
cell growth was seen on PPMS both using WST-1 assays and
Live/Dead analysis up to day 7. Similar saturation was also
obtained after 6 days by Horning et al. (2008), who used porous
poly lactic acid microspheres of 160 µm with ∼16 µm pore
diameter as the scaffold for the development of breast cancer
model seeding with MCF7.
Collagen, a key component of ECM, maintains the structural
integrity (Yamada and Cukierman, 2007), facilitates cell
attachment and proliferation (Horning et al., 2008), and is
required for the growth of cells (Gillette et al., 2008). While
greater cell attachment was observed on PPMS than PLGAMS,
a collagen coating on PPMS further enhanced cell attachment
and proliferation. Immunochemistry confirmed the successful
coating of collagen on PPMS. The possibility of non-specific
binding of primary antibodies was eliminated by the blocking
process with 5% BSA solution prior to incubation with primary
anti-collagen monoclonal antibodies followed by 4–5 washing
cycles that eliminated any absorption on sphere surfaces.
Following collagen coating and optimization of seeding
density, the Col-PPMS were used for co-culturing A549 and
MRC-5 cells. It has been reported that the interplay of malignant
and non-malignant cells in the tumor microenvironment has
a major effect on cancer dynamics. In particular, fibroblasts
have been reported to stimulate invasive behavior and metastasic
activities of A549 both on 2D and on collagen-coated matrices
(Ryszawy et al., 2018; Miyazaki et al., 2019). A549 also exhibited
greater drug resistance with more DNA repair potential in
the presence of WI-38 fibroblasts (Kobayashi et al., 2017).
Furthermore, growth rate of A549 was also reported to be
higher in MRC-5 co-culture than A549 alone (Chen et al., 2018).
Therefore, to aim for an in vitro lung tumor model which
closely mimics in vivo systems, we incorporated A549 lung
adenocarcinoma cells co-cultured with MRC-5 lung fibroblasts
on the collagen-coated porous particles (representing ECM). To
the best of our knowledge, there is no reports of equivalent
in vitro systems used for drug testing. Significantly higher
A549 and MRC-5 attachment and growth was observed on
the Col-PPMS than on PPMS. MRC-5 only favored Col-PPMS
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FIGURE 8 | In vitro drug screening studies. Comparative in vitro screening of
anti-cancer drugs on A549-MRC-5 monolayer and col-PPMS co-culture
treatment groups after 72 h of treatment showed significant difference in cell
viability between both cultures. The col-PPMS-based cultures showing
significant higher resistance to the drugs than monolayer cultures.
Significance was analyzed by Student’s t-test (*p < 0.001, #p < 0.01).
rather than non-coated PPMS; meanwhile, A549 were able
to grow on both scaffold and at higher rate on Col-PPMS.
The collagen coating may have facilitated better fibroblast
growth (Miyazaki et al., 2019), while the aggressive nature
of the cancerous cell line A549 may have allowed them to
grow on both scaffolds. For skin tissue regeneration, Chen
et al. have shown that the collagen coated micro sponges
formed across the PLGA based mesh improved the proficiency
of cell attachment and uniform proliferation of skin dermal
fibroblasts (Chen et al., 2005). Similarly, Truong et al. (2012)
demonstrated the use of different types and arrangement of
collagen to improve the cell attachment of mouse fibroblasts
on PLGA based fibers. Fibroblasts showed elongated and flat
growth on collagen coated materials (Truong et al., 2012).
Live/Dead staining images also confirmed greater cell death
on the PPMS particles than those of Col-PPMS. Significant
difference in cell viability and proliferation was seen at almost
every timepoint when comparing Col-PPMS and PPMS. On
day 1, significantly higher (p < 0.01) cell attachment was seen
on Col-PPMS than on PPMS. A pair t-test with two-tailed
distribution yielded a significant difference with p-value = 0.04,
and this confirmed our hypothesis that overall MRC-5 and A549
grow more on collagen-coated PPMS than those on non-coated
PPMS. Recently, there has been an alternative method wherein
cell-derived decellularized matrix (DCM) produced by human
fibroblasts improves cellular differentiation and function with
more realistic in vivo micking model (Satyam et al., 2020). We
propose to use this concept as the replacement of collagen in our
future experiments.
Next, anti-cancer screening was performed on the developed
in vitro lung cancer tumor model and 2D monolayer system.
To the best of our knowledge, this is the first report on a
FIGURE 9 | Fluorescence Live/Dead imaging of monolayered and col-PPMS-cocultured A549 and MRC-5 after 72 h of drug treatment showing greater viability
(green) for col-PPMS co-cultures than for the monolayer co-cultures in almost all cases. For the monolayer co-cultures, most cells were either washed away or
floating due to cell death, following treatment. Insert images are phase contrast images of the same view. Scale bar: 400 µm.
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lung cancer co-culture model developed using porous PLGA
microspheres and evaluated for drug screening. Cis and Gem,
which are used as the first line of chemotherapy for non-
small cell lung cancer, had greater anti-cancer effects on cells
cultured both as a monolayer and on the PPMS. The Col-
PPMS co-cultures showed a significantly higher resistance to
all of the tested drugs when compared to the 2D monolayer
co-culture. Godugu et al. (2013) created alginate matrix for
cancer spheroid development and the authors found out that
IC50 of Docetaxel, Cis, Gem, and 5-fluorouracil against A549 in
3D were about 60-, 18-, 34-, and 30-fold, respectively, higher
than those in 2D. They also observed the same resistance in
3D for H460 cell line (Godugu et al., 2013). The tendency
that cancer cells become more robust in 3D models has not
only been observed in collagen-coated systems, but also in
scaffolds with other coatings. Collagen type I-coated and/or
fibronectin-coated surfaces increased adhesion and proliferation
of cancer cells grown both as monolayers (Zhang et al., 2013)
and on porous polycaprolactone scaffold (Liu M. et al., 2018;
Nayak et al., 2019). Yip and Cho observed significant Dox
resistance of HepG2 human hepatocellular liver carcinoma
spheroids cultured in collagen gel (∼100% viability) compared
to spheroids not cultured in collagen gel (∼20% viability)
(Yip and Cho, 2013) while Liu M. et al. (2018) observed
that human ovarian cancer cell line OV-2008 became much
more resistant to carboplatin, 5-fluorouracil and Ptx when
cultured in a collagen matrix compared to cells cultured in
the absence of collagen. Similarly, in our previous screening
study using A549 cells cultured on fibronectin-coated porous
PLGA microparticles, a two to fourfold higher drug resistance
to Cis, Ptx, Dox, Gem, Cur, and 5-fluorouracil was observed
when compared to 2D cultures (Kuriakose et al., 2019). This
trend has been observed not just for lung cancer cultures
but also for other cancer 3D models. For instance, MCF-7
cells cultured on porous chitosan coated PLA microspheres
by Horning et al. (2008) were ∼21 and ∼12-folds more
resistant to Dox and Ptx, respectively, than 2D cultures.
Bulysheva et al. (2013) reported that HN12 oral and pharyngeal
cancer cell lines grown on electrospun 3D scaffold were
almost completely resisted to 40 nM of Ptx with almost 90%
viability whereas the cells in 2D were very vulnerable with less
than 5% viability.
The greater cell-cell interaction within our model, and the
blocking of drug diffusion to the core due to the compact
arrangement of cells (Millerot-Serrurot et al., 2010; Yip
and Cho, 2013), would represent treatments given in vivo
the co-culture with fibroblasts can also lead to increased
drug resistance when compared to the monoculture model
(Yip and Cho, 2013). It is reported that cancer associated
fibroblasts can release TGF-β (growth factor) and help
in cancer cell metastasis though increased generation of
matrix metalloproteases. This in turn allows increased
proliferation of cancer cells ultimately leading to increase
in the resistance to chemotherapeutic agents (Wu et al.,
2007; Yip and Cho, 2013). Fibroblasts boost the expression of
soluble growth factors, cytokines and chemokines supporting
the tumor cells and survival (Erdogan and Webb, 2017;
Wang et al., 2017). This induces neovascularization and
generation of immunosuppressive environment for enhanced
tumor cell growth (Affo et al., 2017; Katayama et al., 2019;
Monteran and Erez, 2019). Future studies will focus on
mimicking the hypoxic core of tumors using our col-
PPMS model, as well as incorporation of more cells and
cues present in the tumor microenvironment. We will also
further develop the model using human patient-derived
cells to more closely resemble the in vivo conditions for
predictive drug screening.
CONCLUSION
We have successfully synthesized PPMS with large,
interconnected pores. Although PPMS have been used in
various research applications, we report an innovative method
of safe and controlled pore formation using AMS and EDTA on
PLGA microspheres. Controlled pore formation on the PPMS
was achieved by digesting the incorporated AMS. Degradation
studies of formulated PPMS and PLGAMS clearly show that
the PPMS effectively maintained its structural integrity with
time whereas PLGAMS showed shrunken morphology. Collagen
coating of the particles demonstrated significant improvement
in the attachment and proliferation of A549-MRC-5 co-
cultures. To the authors’ knowledge, this is the first study to
use PPMS for the development of in vitro lung tumor model
using A549-MRC5 co-cultures. The PPMS had a robust and
favorable architecture for cell attachment and proliferation
to develop an in vitro lung tumor model. The co-cultures
on PPMS showed greater chemoresistance to the tested anti-
cancer drugs than co-cultures grown as a monolayer. These
studies indicate the potential of the PPMS in the development
of in vitro lung tumor models, which can be used for early,
accurate screening of promising therapeutic agents, and for
studying mechanisms of cancer progression. In the future, we
intend to develop a more physiologically relevant multicellular
model using human patient-derived lung cancer cells and also
attempt to study the mechanism of chemoresistance mediated by
the PPMS scaffold.
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Kapałczyńska, M., Kolenda, T., Przybyła, W., Zaja̧czkowska, M., Teresiak, A., Filas,
V., et al. (2018). 2D and 3D cell cultures – a comparison of different types of
cancer cell cultures. Arch. Med. Sci. 14, 910–919.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 14 July 2020 | Volume 8 | Article 799
fbioe-08-00799 July 9, 2020 Time: 17:2 # 15
Dhamecha et al. Porous Microspheres for Tumor Model Development
Katayama, Y., Uchino, J., Chihara, Y., Tamiya, N., Kaneko, Y., Yamada, T., et al.
(2019). Tumor neovascularization and developments in therapeutics. Cancers
11, 316. doi: 10.3390/cancers11030316
Kleinman, H. K., Klebe, R. J., and Martin, G. R. (1981). Role of collagenous matrices
in the adhesion and growth of cells. J. Cell Biol. 88, 473–485. doi: 10.1083/jcb.
88.3.473
Kobayashi, A., Tengku Ahmad, T. A. F., Autsavapromporn, N., Oikawa, M.,
Homma-Takeda, S., Furusawa, Y., et al. (2017). Enhanced DNA double-
strand break repair of microbeam targeted A549 lung carcinoma cells
by adjacent WI38 normal lung fibroblast cells via bi-directional signaling.
Mutat. Res. Mol. Mech. Mutagen. 803–805, 1–8. doi: 10.1016/j.mrfmmm.2017.
06.006
Kuriakose, A. E., Hu, W., Nguyen, K. T., and Menon, J. U. (2019). Scaffold-
based lung tumor culture on porous PLGA microparticle substrates. PLoS One
14:e0217640. doi: 10.1371/journal.pone.0217640
Lee, D. W., Hwang, S. J., Park, J. B., and Park, H. J. (2003). Preparation
and release characteristics of polymer-coated and blended alginate
microspheres. J. Microencapsul. 20, 179–192. doi: 10.3109/026520403091
78060
Liu, C., Mejia, D. L., Chiang, B., Luker, K. E., and Luker, G. D. (2018).
Hybrid collagen alginate hydrogel as a platform for 3D tumor spheroid
invasion. Acta Biomater. 75, 213–225. doi: 10.1016/j.actbio.2018.
06.003
Liu, M., Zhang, X., Long, C., Xu, H., Cheng, X., Chang, J., et al. (2018). Collagen-
based three-dimensional culture microenvironment promotes epithelial to
mesenchymal transition and drug resistance of human ovarian cancer: in vitro.
RSC Adv. 8, 8910–8919. doi: 10.1039/c7ra13742g
Loessner, D., Stok, K. S., Lutolf, M. P., Hutmacher, D. W., Clements, J. A., and Rizzi,
S. C. (2010). Bioengineered 3D platform to explore cell–ECM interactions and
drug resistance of epithelial ovarian cancer cells. Biomaterials 31, 8494–8506.
doi: 10.1016/j.biomaterials.2010.07.064
Lu, L., Peter, S. J., Lyman, D. M., Lai, H.-L., Leite, S. M., Tamada, J. A.,
et al. (2000). In vitro and in vivo degradation of porous poly(dl-lactic-co-
glycolic acid) foams. Biomaterials 21, 1837–1845. doi: 10.1016/S0142-9612(00)0
0047-8
McMaster, R., Hoefner, C., Hrynevich, A., Blum, C., Wiesner, M., Wittmann,
K., et al. (2019). Tailored melt electrowritten scaffolds for the generation of
sheet-like tissue constructs from multicellular spheroids. Adv. Healthc. Mater.
8:1801326. doi: 10.1002/adhm.201801326
McMillan, K. S., McCluskey, A. G., Sorensen, A., Boyd, M., and
Zagnoni, M. (2016). Emulsion technologies for multicellular tumour
spheroid radiation assays. Analyst 141, 100–110. doi: 10.1039/c5an0
1382h
Millerot-Serrurot, E., Guilbert, M., Fourré, N., Witkowski, W., Said, G., Van Gulick,
L., et al. (2010). 3D collagen type I matrix inhibits the antimigratory effect of
Dox. Cancer Cell Int. 10:26. doi: 10.1186/1475-2867-10-26
Miyazaki, K., Oyanagi, J., Hoshino, D., Togo, S., Kumagai, H., and
Miyagi, Y. (2019). Cancer cell migration on elongate protrusions of
fibroblasts in collagen matrix. Sci. Rep. 9:292. doi: 10.1038/s41598-018-3
6646-z
Monteran, L., and Erez, N. (2019). The dark side of fibroblasts: cancer-
associated fibroblasts as mediators of immunosuppression in the tumor
microenvironment. Front. Immunol. 10:1835. doi: 10.3389/fimmu.2019.
01835
Moreno, L., and Pearson, A. D. J. (2013). How can attrition rates be reduced in
cancer drug discovery? Expert Opin. Drug Discov. 8, 363–368. doi: 10.1517/
17460441.2013.768984
Nayak, B., Balachander, G. M., Manjunath, S., Rangarajan, A., and Chatterjee,
K. (2019). Tissue mimetic 3D scaffold for breast tumor-derived organoid
culture toward personalized chemotherapy. Colloids Surfaces B Biointerfaces
180, 334–343. doi: 10.1016/J.COLSURFB.2019.04.056
Nazarov, R., Jin, H.-J., and Kaplan, D. L. (2004). Porous 3-D scaffolds
from regenerated silk fibroin. Biomacromolecules 5, 718–726. doi: 10.1021/
bm034327e
Onn, A., Isobe, T., Itasaka, S., Wu, W., O’Reilly, M. S., Ki Hong, W., et al. (2003).
Development of an orthotopic model to study the biology and therapy of
primary human lung cancer in nude mice. Clin. Cancer Res. 9, 5532–5539.
Pan, Z., and Ding, J. (2012). Poly (lactide-co-glycolide) porous scaffolds for tissue
engineering and regenerative medicine. Interface Focus 2, 366–377. doi: 10.
1098/rsfs.2011.0123
Patel, N. R., Aryasomayajula, B., Abouzeid, A. H., and Torchilin, V. P.
(2015). Cancer cell spheroids for screening of chemotherapeutics
and drug-delivery systems. Ther. Deliv. 6, 509–520. doi: 10.4155/tde.
15.1
Prasad, V., and Mailankody, S. (2017). Research and development spending to
bring a single cancer drug to market and revenues after approval. JAMA Intern.
Med. 177, 1569–1575.
Rho, J. K., Choi, Y. J., Lee, J. K., Ryoo, B.-Y., Yang, S. H., Kim, C. H., et al.
(2009). Epithelial to mesenchymal transition derived from repeated exposure
to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small
cell lung cancer cell line. Lung Cancer 63, 219–226. doi: 10.1016/j.lungcan.2008.
05.017
Ryszawy, D., Rolski, F., Ryczek, K., Catapano, J., Wróbel, T., Michalik, M., et al.
(2018). Invasive bronchial fibroblasts derived from asthmatic patients activate
lung cancer A549 cells in vitro. Oncol. Lett. 16, 6582–6588. doi: 10.3892/ol.2018.
9462
Sahoo, S. K., Panda, A. K., and Labhasetwar, V. (2005). Characterization of
porous PLGA/PLA microparticles as a scaffold for three dimensional growth
of breast cancer cells. Biomacromolecules 6, 1132–1139. doi: 10.1021/bm049
2632
Satyam, A., Tsokos, M. G., Tresback, J. S., Zeugolis, D. I., and Tsokos, G. C. (2020).
Cell-derived extracellular matrix-rich biomimetic substrate supports podocyte
proliferation, differentiation, and maintenance of native phenotype. Adv. Funct.
Mater. doi: 10.1002/adfm.201908752. [Epub ahead of print].
Siegel, R. L., Miller, K. D., and Jemal, A. (2019). Cancer statistics, 2019. CA Cancer
J. Clin. 69, 7–34.
Siepmann, J., Elkharraz, K., Siepmann, F., and Klose, D. (2005). How
autocatalysis accelerates drug release from PLGA-based microparticles: a
quantitative treatment. Biomacromolecules 6, 2312–2319. doi: 10.1021/bm050
228k
Tibbitt, M. W., and Anseth, K. S. (2009). Hydrogels as extracellular matrix
mimics for 3D cell culture. Biotechnol. Bioeng. 103, 655–663. doi: 10.1002/bit.
22361
Truong, Y. B., Glattauer, V., Briggs, K. L., Zappe, S., and Ramshaw,
J. A. M. (2012). Collagen-based layer-by-layer coating on electrospun polymer
scaffolds. Biomaterials 33, 9198–9204. doi: 10.1016/j.biomaterials.2012.
09.012
Wang, X., and Yang, P. (2008). In vitro differentiation of mouse embryonic stem
(mES) cells using the hanging drop method. J. Vis. Exp. 2008:825.
Wang, Y., Gan, G., Wang, B., Wu, J., Cao, Y., Zhu, D., et al. (2017).
Cancer-associated fibroblasts promote irradiated cancer cell recovery
through autophagy. EBioMedicine 17, 45–56. doi: 10.1016/j.ebiom.2017.
02.019
Wu, L., and Ding, J. (2004). In vitro degradation of three-dimensional porous
poly(D, L-Lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials,
25, 5821–5830. doi: 10.1016/j.biomaterials.2004.01.038
Wu, L., and Ding, J. (2005). Effects of porosity and pore size on in vitro degradation
of three-dimensional porous poly (D, L-lactide-co-glycolide) scaffolds for tissue
engineering. J. Biomed. Mater. Res. Part A 75, 767–777. doi: 10.1002/jbm.a.
30487
Wu, X., Xie, G., and Chen, D. (2007). Hypoxia and hepatocellular carcinoma: the
therapeutic target for hepatocellular carcinoma. J. Gastroenterol. Hepatol. 22,
1178–1182. doi: 10.1111/j.1440-1746.2007.04997.x
Yakavets, I., Yankovsky, I., Millard, M., Lamy, L., Lassalle, H.-P., Wiehe, A.,
et al. (2017). The alteration of temoporfin distribution in multicellular tumor
spheroids by β-cyclodextrins. Int. J. Pharm. 529, 568–575. doi: 10.1016/j.
ijpharm.2017.07.037
Yamada, K. M., and Cukierman, E. (2007). Modeling tissue morphogenesis and
cancer in 3D. Cell 130, 601–610. doi: 10.1016/j.cell.2007.08.006
Yang, Y., Zhao, Y., Tang, G., Li, H., Yuan, X., and Fan, Y. (2008). In vitro
degradation of porous poly(l-lactide-co-glycolide)/β-tricalcium phosphate
(PLGA/β-TCP) scaffolds under dynamic and static conditions. Polym.
Degrad. Stab. 93, 1838–1845. doi: 10.1016/j.polymdegradstab.2008.
07.007
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 15 July 2020 | Volume 8 | Article 799
fbioe-08-00799 July 9, 2020 Time: 17:2 # 16
Dhamecha et al. Porous Microspheres for Tumor Model Development
Yip, D., and Cho, C. H. (2013). A multicellular 3D heterospheroid model of
liver tumor and stromal cells in collagen gel for anti-cancer drug testing.
Biochem. Biophys. Res. Commun. 433, 327–332. doi: 10.1016/J.BBRC.2013.
03.008
Yuan, H., Miao, J., Du, Y.-Z., You, J., Hu, F.-Q., and Zeng, S. (2008). Cellular
uptake of solid lipid nanoparticles and cytotoxicity of encapsulated Ptx in
A549 cancer cells. Int. J. Pharm. 348, 137–145. doi: 10.1016/j.ijpharm.2007.
07.012
Zhang, K., Yan, S., Li, G., Cui, L., and Yin, J. (2015). In-situ birth of MSCs
multicellular spheroids in poly(l-glutamic acid)/chitosan scaffold for hyaline-
like cartilage regeneration. Biomaterials 71, 24–34. doi: 10.1016/j.biomaterials.
2015.08.037
Zhang, W., Choi, D. S., Nguyen, Y. H., Chang, J., and Qin, L. (2013). Studying
cancer stem cell dynamics on PDMS surfaces for microfluidics device design.
Sci. Rep. 3:2332. doi: 10.1038/srep02332
Zhu, H., Srivastava, R., and McShane, M. J. (2005). Spontaneous loading of
positively charged macromolecules into alginate-templated polyelectrolyte
multilayer microcapsules. Biomacromolecules 6, 2221–2228. doi: 10.1021/
bm0501656
Zhu, W.-T., Liu, S.-Y., Wu, L., Xu, H.-L., Wang, J., Ni, G.-X., et al. (2017). Delivery
of Cur by directed self-assembled micelles enhances therapeutic treatment of
non-small-cell lung cancer. Int. J. Nanomedicine 12, 2621–2634. doi: 10.2147/
ijn.s128921
Zhuo, W., Zhang, L., Zhu, Y., Zhu, B., and Chen, Z. (2015). Fisetin, a dietary
bioflavonoid, reverses acquired Cis-resistance of lung adenocarcinoma cells
through MAPK/Survivin/Caspase pathway. Am. J. Transl. Res. 7, 2045–2052.
Zu, Y., Zhang, Y., Zhao, X., Shan, C., Zu, S., Wang, K., et al. (2012). Preparation
and characterization of chitosan–polyvinyl alcohol blend hydrogels for the
controlled release of nano-insulin. Int. J. Biol. Macromol. 50, 82–87. doi: 10.
1016/j.ijbiomac.2011.10.006
Conflict of Interest: The authors declare that the research was conducted in the
absence of any commercial or financial relationships that could be construed as a
potential conflict of interest.
Copyright © 2020 Dhamecha, Le, Movsas, Gonsalves and Menon. This is an open-
access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Bioengineering and Biotechnology | www.frontiersin.org 16 July 2020 | Volume 8 | Article 799
